<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02670811</url>
  </required_header>
  <id_info>
    <org_study_id>VAGB 001</org_study_id>
    <nct_id>NCT02670811</nct_id>
  </id_info>
  <brief_title>Antihypertensive Effect of Fermented Milk With Lactococcus Lactis on Prehypertensive Subjects</brief_title>
  <official_title>Randomized Double-blind Controlled Clinical Study of the Antihypertensive Effect of Fermented Milk With Lactococcus Lactis NRRL-B50571</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de Investigación en Alimentación y Desarrollo A.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro de Investigación en Alimentación y Desarrollo A.C.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the present work was to evaluate the antihypertensive effect associated with
      the consumption of fermented milk with Lactococcus lactis NRRL-B50571 on prehypertensive
      subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double-blind randomized controlled clinical study of an 8-week intervention with 36
      hypertensive subjects was carried out to evaluate the antihypertensive effect of fermented
      milk with Lactococcus lactis NRRL-B50571. Once obtained the informed consent; volunteers were
      randomized into two groups (n=18) to either receive 150 mL daily: fermented milk with
      Lactococcus lactis NRRL-B50571 (intervention group) or artificially acidified milk as control
      (placebo). Both drinks were consumed daily. Participants were asked not to change their diet
      or lifestyle during the intervention. We applied intention to treat for those participants
      who did not have good adherence and those who withdraw the study. The outcomes between groups
      were analyzed using an independent sample Student t test, with a P value of 0.05 or less (two
      sided) when there was statistical significance; using statistical software.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic Blood Pressure Measurements</measure>
    <time_frame>Baseline to 10 weeks</time_frame>
    <description>From randomization (baseline), eight weeks of intervention and two weeks after intervention was over.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure Measurements</measure>
    <time_frame>Baseline to 10 weeks</time_frame>
    <description>From randomization (baseline), eight weeks of intervention and two weeks post-treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol Measurements</measure>
    <time_frame>Baseline and 8th week</time_frame>
    <description>Total cholesterol in baseline and after 8 weeks of treatment (Intake period).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low Density Lipoproteins Measurements</measure>
    <time_frame>Baseline and 8th week</time_frame>
    <description>Low density lipoproteins measurements in baseline and after 8 weeks of treatment (intake period).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High Density Lipoproteins</measure>
    <time_frame>Baseline and 8th week</time_frame>
    <description>High density lipoproteins measurements in baseline and after 8 weeks of treatment (intake period).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides Measurements</measure>
    <time_frame>Baseline and 8th week</time_frame>
    <description>Triglycerides measurements in baseline and after 8 weeks of treatment (intake period).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Daily consumption of 150 mL of artificially acidified milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fermented milk</intervention_name>
    <description>150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acidified milk</intervention_name>
    <description>150 mL daily of artificially acidified milk</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systolic blood pressure &gt;130 mmHg

          -  Diastolic blood pressure &gt; 85 mmHg

        Exclusion Criteria:

          -  Pregnant women

          -  Cardiovascular diseases

          -  Diabetes

          -  Cancer

          -  Dairy allergy

          -  Lactose intolerance

          -  Patients receiving angiotensin converting enzyme inhibitors as pharmacological therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Belinda Vallejo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centro de Investigación en Alimentación y Desarrollo A.C.</affiliation>
  </overall_official>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2016</study_first_posted>
  <results_first_submitted>July 5, 2016</results_first_submitted>
  <results_first_submitted_qc>August 17, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 11, 2016</results_first_posted>
  <last_update_submitted>October 11, 2016</last_update_submitted>
  <last_update_submitted_qc>October 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro de Investigación en Alimentación y Desarrollo A.C.</investigator_affiliation>
    <investigator_full_name>Belinda Vallejo Galland, PhD</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Fermented Milk</keyword>
  <keyword>Clinical Study</keyword>
  <keyword>Randomized</keyword>
  <keyword>Double-blind</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Participants who were eligible were asked to sign informed consents. Afterwards all baseline measurements were taken two weeks before randomization and group formations. Subjects who did not fulfill the inclusion criteria were explained why they were not eligible for this study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="36"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.5" spread="11.7"/>
                    <measurement group_id="B2" value="44.6" spread="9.2"/>
                    <measurement group_id="B3" value="42.5" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Mexico</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic blood pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="131.8" spread="5.6"/>
                    <measurement group_id="B2" value="134.3" spread="7"/>
                    <measurement group_id="B3" value="133.1" spread="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic blood pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87.7" spread="5.1"/>
                    <measurement group_id="B2" value="89.3" spread="5.8"/>
                    <measurement group_id="B3" value="88.6" spread="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80.5" spread="14.6"/>
                    <measurement group_id="B2" value="85.8" spread="18.2"/>
                    <measurement group_id="B3" value="83.2" spread="16.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.63" spread="0.1"/>
                    <measurement group_id="B2" value="1.67" spread="0.1"/>
                    <measurement group_id="B3" value="1.65" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total cholesterol</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="190.1" spread="43.6"/>
                    <measurement group_id="B2" value="178.1" spread="26"/>
                    <measurement group_id="B3" value="184.1" spread="35.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Low density lipoprotein</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="127.1" spread="43"/>
                    <measurement group_id="B2" value="114.7" spread="26"/>
                    <measurement group_id="B3" value="120.9" spread="35.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>High density lipoprotein</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.9" spread="8.7"/>
                    <measurement group_id="B2" value="37.8" spread="6.5"/>
                    <measurement group_id="B3" value="37.9" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Triglycerides</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="137.5" spread="42.3"/>
                    <measurement group_id="B2" value="144.3" spread="63.5"/>
                    <measurement group_id="B3" value="141" spread="53.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Systolic Blood Pressure Measurements</title>
        <description>From randomization (baseline), eight weeks of intervention and two weeks after intervention was over.</description>
        <time_frame>Baseline to 10 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure Measurements</title>
          <description>From randomization (baseline), eight weeks of intervention and two weeks after intervention was over.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131.8" spread="5.7"/>
                    <measurement group_id="O2" value="134.3" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.1" spread="13.6"/>
                    <measurement group_id="O2" value="127.4" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.3" spread="9.6"/>
                    <measurement group_id="O2" value="125.8" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120" spread="11.4"/>
                    <measurement group_id="O2" value="127.1" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.1" spread="14.2"/>
                    <measurement group_id="O2" value="125" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 5 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.6" spread="12.3"/>
                    <measurement group_id="O2" value="124.8" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.4" spread="11.6"/>
                    <measurement group_id="O2" value="126.4" spread="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 7 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.9" spread="12.6"/>
                    <measurement group_id="O2" value="125.6" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.5" spread="8.3"/>
                    <measurement group_id="O2" value="127.6" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122.3" spread="12.9"/>
                    <measurement group_id="O2" value="127.3" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124" spread="12.6"/>
                    <measurement group_id="O2" value="128" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The primary outcome, systolic blood pressure (mmHg), between groups was analyzed using an independent sample student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The primary outcome, systolic blood pressure (mmHg), was analyzed using a paired student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Blood Pressure Measurements</title>
        <description>From randomization (baseline), eight weeks of intervention and two weeks post-treatment.</description>
        <time_frame>Baseline to 10 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure Measurements</title>
          <description>From randomization (baseline), eight weeks of intervention and two weeks post-treatment.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.7" spread="5.1"/>
                    <measurement group_id="O2" value="89.4" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.3" spread="9.5"/>
                    <measurement group_id="O2" value="85.9" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.8" spread="8"/>
                    <measurement group_id="O2" value="84.2" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.9" spread="8"/>
                    <measurement group_id="O2" value="85.7" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.4" spread="10.7"/>
                    <measurement group_id="O2" value="84.4" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 5 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.7" spread="9.1"/>
                    <measurement group_id="O2" value="84.5" spread="8.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.6" spread="9.6"/>
                    <measurement group_id="O2" value="84.1" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 7 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.7" spread="11.1"/>
                    <measurement group_id="O2" value="84.9" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.7" spread="5.9"/>
                    <measurement group_id="O2" value="86.4" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.3" spread="9.3"/>
                    <measurement group_id="O2" value="87.1" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 Post-Treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.7" spread="9.1"/>
                    <measurement group_id="O2" value="86.3" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The secondary outcome, diastolic blood pressure (mmHg), between groups was analyzed using an independent sample student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Cholesterol Measurements</title>
        <description>Total cholesterol in baseline and after 8 weeks of treatment (Intake period).</description>
        <time_frame>Baseline and 8th week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
          </group>
        </group_list>
        <measure>
          <title>Total Cholesterol Measurements</title>
          <description>Total cholesterol in baseline and after 8 weeks of treatment (Intake period).</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="190.1" spread="43.6"/>
                    <measurement group_id="O2" value="178.1" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="180.7" spread="36.1"/>
                    <measurement group_id="O2" value="189.8" spread="39.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The secondary outcome, total cholesterol (mg/dL), between groups was analyzed using an independent sample student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Low Density Lipoproteins Measurements</title>
        <description>Low density lipoproteins measurements in baseline and after 8 weeks of treatment (intake period).</description>
        <time_frame>Baseline and 8th week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
          </group>
        </group_list>
        <measure>
          <title>Low Density Lipoproteins Measurements</title>
          <description>Low density lipoproteins measurements in baseline and after 8 weeks of treatment (intake period).</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="127.1" spread="43"/>
                    <measurement group_id="O2" value="114.7" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.6" spread="37.8"/>
                    <measurement group_id="O2" value="122.7" spread="31.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The secondary outcome, low density lipoprotein (mg/dL), between groups was analyzed using an independent sample student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>High Density Lipoproteins</title>
        <description>High density lipoproteins measurements in baseline and after 8 weeks of treatment (intake period).</description>
        <time_frame>Baseline and 8th week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
          </group>
        </group_list>
        <measure>
          <title>High Density Lipoproteins</title>
          <description>High density lipoproteins measurements in baseline and after 8 weeks of treatment (intake period).</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.9" spread="8.7"/>
                    <measurement group_id="O2" value="37.8" spread="6.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.2" spread="8.1"/>
                    <measurement group_id="O2" value="42.4" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The secondary outcome, high density lipoproteins (mg/dL), between groups were analyzed using an independent sample student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglycerides Measurements</title>
        <description>Triglycerides measurements in baseline and after 8 weeks of treatment (intake period).</description>
        <time_frame>Baseline and 8th week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides Measurements</title>
          <description>Triglycerides measurements in baseline and after 8 weeks of treatment (intake period).</description>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137.5" spread="42.3"/>
                    <measurement group_id="O2" value="144.3" spread="63.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8 Intake Period</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.6" spread="44.3"/>
                    <measurement group_id="O2" value="124.9" spread="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <p_value_desc>The secondary outcome, triglycerides (mg/dL), between groups was analyzed using an independent sample student t test.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Daily consumption of 150 mL of fermented milk with Lactococcus lactis for 8 weeks
Fermented milk: 150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Daily consumption of 150 mL of artificially acidified milk
Acidified milk: 150 mL daily of artificially acidified milk</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Belinda Vallejo Galland</name_or_title>
      <organization>Centro de Investigación en Alimentación y Desarrollo, A.C.</organization>
      <phone>526622892400 ext 365</phone>
      <email>vallejo@ciad.mx</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

